Steven L. Hoerter, Director of C4 Therapeutics CCCC, has filed 1 purchase and 4 sales on the open market. Over the past 12 months that comes to a net purchase of $265K. The latest trade was on 06/24.

SH

SH

Steven L. Hoerter

Director

Company

C4 Therapeutics CCCC

First filing

23/02/16

Trades

33 trades

Buys / sales

1 / 4

12-month net buying

$265K

Last trade

06/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
MBX BiosciencesMBX	Open-market buy	25/10/17	25/10/20	20,000 sh	$13.25	$265,000	No record
DP Deciphera Pharmaceuticals	Open-market sale	23/12/13	23/12/14	30,664 sh	$15.37	$471,305.68	−29.6%
DP Deciphera Pharmaceuticals	Open-market sale	23/10/30	23/10/31	21,573 sh	$12.02	$259,307.46	−34.5%
DP Deciphera Pharmaceuticals	Open-market sale	23/03/21	23/03/23	7,500 sh	$15.57	$116,775	−100.0%
DP Deciphera Pharmaceuticals	Open-market sale	23/02/14	23/02/16	30,045 sh	$16.00	$480,720	−80.0%